Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

French reimbursement commission tasks set out

This article was originally published in Clinica

Executive Summary

June 30 saw the somewhat belated publication in the French Journal officiel of the Decision setting out the rules of modus operandi of the French Supreme Healthcare Authority (HAS), which began operations on January 1. The Decision sets out the role of the commission responsible for the evaluation of products and service (CEPP). This is one of seven commissions within HAS answerable to the management board, or college. The Decision confirms that the CEPP is responsible for deciding which products should appear on the list of reimbursable products and procedures. Its remit covers single-use medical devices, human tissues and cells, and all other healthcare products other than medicines, and procedures with which they are associated. For more details on the role of HAS and CEPP, see the Clinica Review of 2004.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055676

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel